News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co. (MRK)’s Keytruda Finds Fast Entry Into China Via Medical-Tourism Push



9/26/2016 5:58:32 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Merck & Co.’s immunotherapy cancer drug Keytruda is finding its way into China as the first imported drug approved for use under a pilot program on the resort island of Hainan intended to boost medical tourism.

The fast-track entry for Keytruda into China, albeit limited, is likely to give Merck an advantage in competing with Bristol-Myers Squibb Co., which is also seeking approval in China for its rival drug Opdivo. Both companies had faced a lengthy approval process required by Chinese regulators.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES